Funds And Strategies
  • Business
  • Stocks
  • World News
  • Investing
  • Business
  • Stocks
  • World News
  • Investing

Funds And Strategies

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin July 28, 2025
July 28, 2025
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

previous post
Maiden Drill Program Commences at Oasis Uranium Project
next post
Things are getting better at Boeing under CEO Ortberg, but can he keep it going?

Related Posts

High-grade RC assays and visible gold in Menzies...

September 4, 2025

Skyharbour Enters into Major Strategic Agreement with Denison...

November 17, 2025

Drill Program Operations Commence at El Campo

November 27, 2025

Acceleration of RAD204 Phase 1 dose escalation trial

May 12, 2025

Silver Crown Royalties Announces Closing of Final Tranche...

April 28, 2025

Alzheimer’s Disease Treatment Stocks: 3 Biggest NASDAQ Companies

May 28, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (257)
    • Investing (1,578)
    • Stocks (206)
    • World News (648)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 fundsandstrategies.com | All Rights Reserved